CD133 and BMI1 expressions and its prognostic role in primary glioblastoma

December 2015
Journal of Genetics;Dec2015, Vol. 94 Issue 4, p689
Academic Journal
Glioblastoma is the most common malignant brain tumour, generated by bulk of malignant cancer stem cells, which express various stem cell factors like CD133, BMI1 and nestin. There are several studies which show the importance of CD133 in cancer, but the function and interaction with other major oncogenes and tumour suppressor genes is still not understood. This study aimed to analyse the expression of CD133 mRNA and its correlations with BMI1 protein expression and TP53 mutations in newly diagnosed glioblastoma patients and its role in prognosis. Overexpression of CD133 mRNA and BMI1 protein was found in 47.6 and 76.2% patients respectively and TP53 mutations was seen in 57.1% of patients in our study. There was no correlation among TP53 mutations and expressions of CD133 and BMI1. We found that high level of BMI1 expression was favourable for the patient survival (P = 0.0075) and high CD133 mRNA expression was unfavourable for the patient survival (P = 0.0226). CD133 mRNA and BMI1 protein expression could independently predict the glioblastoma patient survival in multivariate analysis. In conclusion, the overexpression of these stem cell markers is a common event in glioblastoma progression and could be used as potential prognostic markers.


Related Articles

  • HES6 gene is selectively overexpressed in glioma and represents an important transcriptional regulator of glioma proliferation. Haapa-Paananen, S; Kiviluoto, S; Waltari, M; Puputti, M; Mpindi, J P; Kohonen, P; Tynninen, O; Haapasalo, H; Joensuu, H; Perälä, M; Kallioniemi, O // Oncogene;3/8/2012, Vol. 31 Issue 10, p1299 

    Malignant glioma is the most common brain tumor with 16 000 new cases diagnosed annually in the United States. We performed a systematic large-scale transcriptomics data mining study of 9783 tissue samples from the GeneSapiens database to systematically identify genes that are most...

  • Therapeutic potential of cyclooxygenase-3 inhibitors in the management of glioblastoma. Oksuz, Ersoy; Atalar, Fatmahan; Tanırverdi, Gamze; Bilir, Ayahan; Shahzadi, Andleeb; Yazici, Zeliha // Journal of Neuro-Oncology;Jan2016, Vol. 126 Issue 2, p271 

    In this study we investigated the expression of COX-1, COX-2 and COX-3 mRNA in C6 glioblastoma and normal brain tissues and the effects of acetaminophen, indomethacin or metamizole treatments on the development of C6 glioblastoma in relation with COX inhibition. Glioblastoma cells were...

  • Translational Validation of Personalized Treatment Strategy Based on Genetic Characteristics of Glioblastoma. Oh, Young Taek; Cho, Hee Jin; Kim, Jinkuk; Lee, Ji-Hyun; Rho, Kyoohyoung; Seo, Yun-Jee; Choi, Yeon-Sook; Jung, Hye Jin; Song, Hyeon Suk; Kong, Doo-Sik; Seol, Ho Jun; Lee, Jung-Il; Yoon, Yeup; Kim, Sunghoon; Nam, Do-Hyun; Joo, Kyeung Min // PLoS ONE;Aug2014, Vol. 9 Issue 8, p1 

    Glioblastoma (GBM) heterogeneity in the genomic and phenotypic properties has potentiated personalized approach against specific therapeutic targets of each GBM patient. The Cancer Genome Atlas (TCGA) Research Network has been established the comprehensive genomic abnormalities of GBM, which...

  • A BMP7 variant inhibits the tumorigenic potential of glioblastoma stem-like cells. Tate, C M; Pallini, R; Ricci-Vitiani, L; Dowless, M; Shiyanova, T; D'Alessandris, G Q; Morgante, L; Giannetti, S; Larocca, L M; di Martino, S; Rowlinson, S W; De Maria, R; Stancato, L // Cell Death & Differentiation;Oct2012, Vol. 19 Issue 10, p1644 

    Glioblastoma multiforme (GBM) is among the most aggressive tumor types and is essentially an incurable malignancy characterized by resistance to chemo-, radio-, and immunotherapy. GBM is maintained by a hierarchical cell organization that includes stem-like, precursor, and differentiated cells....

  • Upregulation of miR-181s reverses mesenchymal transition by targeting KPNA4 in glioblastoma. Wang, Hongjun; Tao, Tao; Yan, Wei; Feng, Yan; Wang, Yongzhi; Cai, Jinquan; You, Yongping; Jiang, Tao; Jiang, Chuanlu // Scientific Reports;8/21/2015, p13072 

    The goal of this work was to explore the most effective miRNAs affecting glioblastoma multiforme (GBM) phenotype transition and malignant progression. We annotated 491 TCGA samples' miRNA expression profiles according to their mRNA-based subtypes and found that the mesenchymal tumors had...

  • Identifying Causal Genes and Dysregulated Pathways in Complex Diseases. Yoo-Ah Kim; Wuchty, Stefan; Przytycka, Teresa M. // PLoS Computational Biology;Mar2011, Vol. 7 Issue 3, p1 

    In complex diseases, various combinations of genomic perturbations often lead to the same phenotype. On a molecular level, combinations of genomic perturbations are assumed to dys-regulate the same cellular pathways. Such a pathwaycentric perspective is fundamental to understanding the...

  • Nuclear survivin expression predicts poorer prognosis in glioblastoma. Katsuyuki Shirai; Yoshiyuki Suzuki; Kuniyuki Oka; Shin-ei Noda; Hiroyuki Katoh; Yoshihiko Suzuki; Jun Itoh; Hideaki Itoh; Shogo Ishiuchi; Hideyuki Sakurai; Masatoshi Hasegawa; Takashi Nakano // Journal of Neuro-Oncology;Feb2009, Vol. 91 Issue 3, p353 

    Abstract  Survivin is a member of the inhibitor of apoptosis family, and is expressed in various malignant tumors. Survivin overexpression has been reported to be a poorer prognostic factor in various malignancies. However, the prognostic value of survivin expression in patients with...

  • Integrative Multi-omics Module Network Inference with Lemon-Tree. Bonnet, Eric; Calzone, Laurence; Michoel, Tom // PLoS Computational Biology;Feb2015, Vol. 11 Issue 2, p1 

    Module network inference is an established statistical method to reconstruct co-expression modules and their upstream regulatory programs from integrated multi-omics datasets measuring the activity levels of various cellular components across different individuals, experimental conditions or...

  • Identification of an Efficient Gene Expression Panel for Glioblastoma Classification. Crisman, Thomas J.; Zelaya, Ivette; Laks, Dan R.; Zhao, Yining; Kawaguchi, Riki; Gao, Fuying; Kornblum, Harley I.; Coppola, Giovanni // PLoS ONE;11/17/2016, Vol. 11 Issue 11, p1 

    We present here a novel genetic algorithm-based random forest (GARF) modeling technique that enables a reduction in the complexity of large gene disease signatures to highly accurate, greatly simplified gene panels. When applied to 803 glioblastoma multiforme samples, this method allowed the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics